5th Edition of
International Public Health Conference
March 19-21, 2026 | Singapore
Public Health Genetics
The application of genetic knowledge for improving public health is known as public health genomics. This is seen as more precise, genetically-tailored preventative care and disease therapies that are more effective and targeted for each patient. Public health genomics is a developing field of study that evaluates the influence of genes and their interactions with behaviour, nutrition, and the environment on the health of the population, according to the Centers for Disease Control and Prevention (U.S.). Genomics in public health is a relatively new area. Public health genomics initiatives have been launched by a variety of think tanks, institutions, and governments (including those in the U.S., UK, and Australia). Human genome research is producing new information that is modifying public health policies and practises.
David John Wortley
International Society of Digital Medicine (ISDM), United Kingdom
Bob Esquerre
Esquerre Fitness Group International, United States
Kyrisakos Kouveliotis
Berlin School of Business and Innovation, GermanySubmit your abstract Today
Title : Spillover at the edge: Mapping zoonotic disease risk in the wildland-urban interface
Roman Sharnuud, University of Tennessee, United States
Title : AI for good? Expanding our understanding of opinion leaders in a changing digital landscape
Amelia Burke Garcia, NORC at the University of Chicago, United States
Title : Confidence as care: Empowering under represented voices in public health leadership and community engagement
Sheena Yap Chan, The Tao of Self-Confidence, Canada
Title : Redefining eHealth literacy for the digital age: A scoping review to advance equity, engagement, and behaviour change
Comfort Sanuade, Concordia University, Canada
Title : Innovative approaches in public health leadership: Empowering communities for resilient health systems
Mohammad Kamal Hussain, Umm Al-Qura University, Saudi Arabia
Title : Assessing human exposure to key chemical carcinogens diagnostic approaches and interpretation
Vladan Radosavljevic, Military Medical Academy, Serbia